[1]
D. Dimitriadis, I. Terzi, I. Dragoumani, K. Liapis, and D. Papazoglou, “Tuberculous meningitis and hemophagocytic lymphohistiocytosis in a patient on adalimumab: diagnostic challenges in the setting of suspected non-tuberculous mycobacteria co-infection”, EJCRIM, vol. 12, no. 7, Jun. 2025, doi: 10.12890/2025_005590.